Liquidia Corp. (LQDA)
40.54
-1.86
(-4.39%)
USD |
NASDAQ |
Feb 10, 16:00
40.53
-0.01
(-0.02%)
After-Hours: 20:00
Liquidia EPS Diluted (Quarterly) : -0.0409 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.133 |
| Merck & Co., Inc. | 1.191 |
| Indivior Pharmaceuticals, Inc. | 0.3256 |
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.533M |
| Revenue (Quarterly) | 54.34M |
| Total Expenses (Quarterly) | 57.88M |
| Enterprise Value | 3.568B |
| Gross Profit Margin (Quarterly) | 93.65% |
| Profit Margin (Quarterly) | -6.50% |
| Earnings Yield | -3.53% |
| Normalized Earnings Yield | -3.528 |